Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores)

BMC Nephrology

Table 3 Association between MEST-C score and baseline eGFR in STOP-IgAN patients

	Mean eGFR^a^,^b	p-value
Mesangial hypercellularity		0.674
M0	62 ± 26
M1	65 ± 34
Endocapillary hypercellularity		0.308
E0	64 ± 27
E1	53 ± 34
Segmental glomerulosclerosis		0.422
S0	74 ± 34
S1	61 ± 27
Tubular atrophy/Interstitial fibrosis		< 0.0001
T0	75 ± 28
T1/2	45 ± 16
Crescents		0.815
C0	62 ± 29
C1/2	64 ± 25

ISSN: 1471-2369